PTGS2 and Alzheimer disease: To determine whether Nosustrophine treatment affected neuroinflammation-related gene expression caused by AD-associated neuropathology, we analyzed IL-1β, IL-6, TNFα, COX-2 and NOS3 mRNA levels in older (8–9-month-old) APP/BIN1/COPS5 mice.